Hydrochloric Acid → 9-Benzyl-2-chloro-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one
反応式
C([O:3][C:4](=O)[CH2:5][CH2:6][N:7]([CH2:18][C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1)[C:8]1[C:13]([N+:14]([O-])=O)=[CH:12][N:11]=[C:10]([Cl:17])[N:9]=1)C.Cl>C(O)C>[CH2:18]([N:7]1[CH2:6][CH2:5][C:4](=[O:3])[NH:14][C:13]2[CH:12]=[N:11][C:10]([Cl:17])=[N:9][C:8]1=2)[C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1参加物
4
実験手順
To a solution of 1.1 g (0.003 mole) of 3-[benzyl-(2-chloro-5-nitro-pyrimidin-4-yl)-amino]-propanoic acid ethyl ester (IV-22) in 20 mL of ethanol was added 1.7 g (0.0075 mole) of stannous chloride dehydrate and 0.5 mL of hydrochloric acid. The mixture was heated at 60 degrees for 2 hrs. The solvent was evaporated under reduced pressure. The residue was taken up in 50 mL of water and extracted three times with 50 mL of ethyl acetate. The combined organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. Purification by silica gel chromatography, eluting with dichloromethane-methanol (100:0-95:5) gave 0.16 g of 9-benzyl-2-chloro-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VI-22) as a white solid.